Business Description
ISEC Healthcare Ltd
ISIN : SG1AD9000001
Description
ISEC Healthcare Ltd is a Singapore based company engaged in providing medical eye care services through its subsidiaries. It also provides ambulatory surgical centers. In addition, the group is also focused on offering general medical services and aesthetic treatment services. The company has two reportable segments, namely Specialized health services, which include the provision of medical care, consultancy, treatment and surgery in the field of ophthalmology; and General health services which includes the provision of general medical and procedural treatment services It generates maximum revenue from the specialized health services segment. The firm operates in Singapore and Malaysia, of which key revenue is derived from Malaysia.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.33 | |||||
Equity-to-Asset | 0.76 | |||||
Debt-to-Equity | 0.15 | |||||
Debt-to-EBITDA | 0.54 | |||||
Interest Coverage | 31.51 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 6.98 | |||||
Beneish M-Score | -2.57 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 22.7 | |||||
3-Year EBITDA Growth Rate | 26 | |||||
3-Year EPS without NRI Growth Rate | 42.2 | |||||
3-Year FCF Growth Rate | 33.9 | |||||
3-Year Book Growth Rate | 2.8 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 2.1 | |||||
9-Day RSI | 11.84 | |||||
14-Day RSI | 23.87 | |||||
6-1 Month Momentum % | -16.3 | |||||
12-1 Month Momentum % | -4.94 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.72 | |||||
Quick Ratio | 1.55 | |||||
Cash Ratio | 1.12 | |||||
Days Inventory | 21.2 | |||||
Days Sales Outstanding | 23.71 | |||||
Days Payable | 16.65 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 3.07 | |||||
Dividend Payout Ratio | 0.71 | |||||
3-Year Dividend Growth Rate | 53.3 | |||||
Forward Dividend Yield % | 3.07 | |||||
5-Year Yield-on-Cost % | 3.61 | |||||
3-Year Average Share Buyback Ratio | -1.4 | |||||
Shareholder Yield % | 3.27 |
Profitability Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 44.28 | |||||
Operating Margin % | 25.75 | |||||
Net Margin % | 18.87 | |||||
FCF Margin % | 14.87 | |||||
ROE % | 16.6 | |||||
ROA % | 12.63 | |||||
ROIC % | 16.33 | |||||
ROC (Joel Greenblatt) % | 68.98 | |||||
ROCE % | 19.96 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 15.63 | |||||
PE Ratio without NRI | 15.63 | |||||
Shiller PE Ratio | 21.84 | |||||
Price-to-Owner-Earnings | 15.63 | |||||
PEG Ratio | 1.5 | |||||
PS Ratio | 3.05 | |||||
PB Ratio | 2.6 | |||||
Price-to-Tangible-Book | 7.5 | |||||
Price-to-Free-Cash-Flow | 20.83 | |||||
Price-to-Operating-Cash-Flow | 12.93 | |||||
EV-to-EBIT | 11.5 | |||||
EV-to-EBITDA | 9.47 | |||||
EV-to-Revenue | 2.98 | |||||
EV-to-FCF | 20.06 | |||||
Price-to-Projected-FCF | 1.14 | |||||
Price-to-DCF (Earnings Based) | 0.91 | |||||
Price-to-DCF (FCF Based) | 0.6 | |||||
Price-to-Median-PS-Value | 0.72 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.94 | |||||
Price-to-Graham-Number | 2.21 | |||||
Earnings Yield (Greenblatt) % | 8.7 | |||||
FCF Yield % | 4.89 | |||||
Forward Rate of Return (Yacktman) % | 21.55 |